Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05572632 · ClinicalTrials.gov registry record · NA
Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD
A NA study of COPD (Chronic Obstructive Pulmonary Disease), sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 387
- Enrollment target
- 3
- Study locations
NCT05572632: Recruiting NA study of COPD (Chronic Obstructive Pulmonary Disease), sponsored by University of California, San Francisco.
NCT05572632 is a NA study of COPD (Chronic Obstructive Pulmonary Disease) that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 387 participants, below the 692-participant average among 9 other COPD (Chronic Obstructive Pulmonary Disease) trials with a reported enrollment target (44% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05572632, a NA study of COPD (Chronic Obstructive Pulmonary Disease), is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 387 participants
- Enrollment target
- 3
- Study locations
Study Summary
Chronic obstructive pulmonary disease (COPD), one of the leading causes of death in the US, disproportionately affects low socioeconomic communities. While few interventions effectively modify the course of COPD and improve outcomes, pulmonary rehabilitation is the one notable exception. However, implementation of this resource-intensive program in real-life settings, and in particular, for underserved communities, has proven to be challenging. Safety-net centers that serve primarily under-insured populations lack financial resources to provide pulmonary rehabilitation. The 10-week COPD Wellness and Plus+ Program directly addresses this gap, and yet, programs like these do not automatically lead to improved outcomes, which leads to the implementation of a Health Advocates program to address participant's social needs and barriers to healthcare.
Primary Outcome
Standardized validated test to measure distance walked in 6 minutes
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL COPD Wellness
- BEHAVIORAL COPD Wellness Plus+
Study Locations (3)
California
- Zuckerberg San Francisco General (ZSFG) Hospital - San Francisco
- Maxine Hall Health Center (MHHC) - San Francisco
- Southeast Health Center (SEHC) - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 387 participants |
| Start Date | 2023-01-19 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What NCT05572632 shows while recruiting
NCT05572632 is an interventional study that assigns participants to a tested intervention. The registered 387 participants enrollment target is mid-sized for trials with a published cap, below the 692-participant average among 9 other COPD (Chronic Obstructive Pulmonary Disease) trials with a reported enrollment target (44% lower).
The record links to 1 condition, with COPD (Chronic Obstructive Pulmonary Disease) appearing as the primary indexed condition, and to 3 interventions - of which Usual Care is the first listed.
NCT05572632 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05572632 about?
NCT05572632 is a clinical study titled "Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD". Chronic obstructive pulmonary disease (COPD), one of the leading causes of death in the US, disproportionately affects low socioeconomic communities. While few interventions effectively modify the course of COPD and improve outcomes, pulmonary rehabilitation is the one notable exception. However, im...
What is the current status of trial NCT05572632?
This trial is currently recruiting. It is a NA study. The enrollment target is 387 participants. The study started on 2023-01-19. Estimated completion is 2027-06-30.
What conditions does trial NCT05572632 study?
This clinical trial studies the following conditions: COPD (Chronic Obstructive Pulmonary Disease).
What interventions are being tested in trial NCT05572632?
The interventions under investigation include: Usual Care (BEHAVIORAL), COPD Wellness (BEHAVIORAL), COPD Wellness Plus+ (BEHAVIORAL).
Who is sponsoring clinical trial NCT05572632?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05572632 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COPD (Chronic Obstructive Pulmonary Disease)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05572632's enrollment target sits among peer trials
387 3rd of 9 higher than 7 of 9 other COPD (Chronic Obstructive Pulmonary Disease) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COPD (Chronic Obstructive Pulmonary Disease) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Photon-counting CT in Chest Imaging
RECRUITING · NA
-
Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation
RECRUITING · NA
-
OMEGA - Dietary Intervention - COPD Trial
RECRUITING · NA
-
University of Michigan COPD Identification Through Lung Cancer Screening Cohort Study - MAP2
RECRUITING
-
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
RECRUITING · Phase 3
-
Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03761108 · 387 participants · Phase 1
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
- NCT06917079 · 387 participants · Phase 1
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- NCT04092010 · 388 participants · NA
Improving Preschool Outcomes by Addressing Maternal Depression in Head Start
- NCT05157880 · 388 participants · NA
Building Resiliency in Dyads of Patients With an ANI Admitted to the Neuro-ICU and Their Informal Caregivers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI